A prominent feature of the developing mammalian brain is the widespread migration of neural progenitor (NP) cells during embryogenesis. A striking example is provided by NP cells born in the ventral forebrain of midgestation stage mice, which subsequently migrate long distances to their final positions in the cortex and olfactory bulb. Previous studies have used two-dimensional histological methods, making it difficult to analyze three-dimensional (3D) migration patterns. Unlike histology, magnetic resonance microimaging (micro-MRI) is a non-destructive, quantitative and inherently 3D imaging method for analyzing mouse embryos. To allow mapping of migrating NP cells with micro-MRI, cells were labeled in situ in the medial (MGE) and lateral (LGE) ganglionic eminences, using targeted in utero ultrasound-guided injection of micron-sized particles of iron-oxide (MPIO). Ex vivo micro-MRI and histology were then performed 5-6 days after injection, demonstrating that the MPIO had magnetically labeled the migrating NP populations, which enabled 3D visualization and automated segmentation of the labeled cells. This approach was used to analyze the distinct patterns of migration from the MGE and LGE, and to construct rostral-caudal migration maps from each progenitor region. Furthermore, abnormal migratory phenotypes were observed in Nkx2.1 −/− embryos, most notably a significant increase in cortical neurons derived from the Nkx2.1 −/− LGE. Taken together, these results demonstrate that MPIO labeling and micro-MRI provide an efficient and powerful approach for analyzing 3D cell migration patterns in the normal and mutant mouse embryonic brain.
Introduction
Cell migration is a key feature of mammalian brain development, with NP cells arising in a number of progenitor regions and subsequently migrating via distinct pathways to take up their final positions in the mature brain. Studies of neural cell migration have largely been performed in the mouse, taking advantage of the vast resource of genetically modified strains to investigate the roles of defined molecular factors on cell migration and specification during brain development. In particular, a number of investigations have revealed that two distinct populations of NP cells are born ventrally in the MGE and LGE, and undergo extensive migration before differentiating into cortical and olfactory bulb interneurons, respectively (Marin et al., 2000; Anderson et al., 2001; Wichterle et al., 2001) (Fig. 1) .
Lacking in classical studies of NP cell movements in the embryonic mouse brain have been efficient methods for analyzing the complex 3D migration patterns. Numerous methods are available for optical labeling of cells in the developing mouse brain, including direct injection of fluorescent dyes or viruses, or genetic labeling via expression of reporter genes using cell-specific promoter-enhancer elements in transgenic or mutant mice. Despite these advances in cell labeling, 3D visualization of cell migration still relies largely on histology, which is inherently two-dimensional and prone to artifacts produced during sectioning and staining. Optical imaging methods such as two-photon microscopy and optical projection tomography provide 3D capability, but are currently limited in penetration to relatively early stages of embryonic brain development, or to superficial regions of later stage embryonic brains.
Micro-MRI provides a combination of relatively high spatial resolution (~50 μm), together with sufficient penetration for whole brain imaging at all developmental stages up to adulthood in mice (Turnbull and Mori, 2007; . For cell labeling applications in the adult mouse and rat brain, micron-sized particles of iron oxide (MPIO) have been the focus of a number of studies, being efficiently taken up by stem cells in culture (Hinds et al., 2003; Shapiro et al., 2005) and in situ by NP cells in the subventricular zone (Shapiro et al., 2006) . By combining T2*-weighted MRI with MPIO labeling in situ in the adult SVZ, migration of NP cells in the rostral migratory stream have been investigated in a number of recent studies (Shapiro et al., 2006; Sumner et al., 2009; Vreys et al., 2010; Granot et al., 2011) . Interestingly, MPIO labeling has also been used to study altered NP migration following injury in the early postnatal rat brain (Yang et al., 2009 ). However, this approach has yet to be applied to the much more extensive neurodevelopmental migration events occurring prior to birth.
The aim of this study was to magnetically label MGE and LGE NP populations for micro-MRI analysis of migration during embryonic brain development in wildtype (WT) mouse embryos and in Nkx2.1 −/− embryos, which lack the physical structure and molecular markers of the MGE. Mid-gestational MGE or LGE cells were labeled in situ by targeted injection of MPIO under the guidance of ultrasound biomicroscopy (UBM), after which labeled NP cell migration was assessed on fixed brain samples using 3D T2*-weighted micro-MRI and histology. Our results demonstrate the utility of this approach for 3D analysis of NP cell migration patterns in the normal and mutant embryonic mouse brain.
Materials & methods

Animals
All mice used in these studies were maintained under protocols approved by the Institutional Animal Care and Use Committee at the New York University School of Medicine. Experiments were first performed in timed-pregnant ICR strain mice, where embryonic day (E)0.5 was defined to be noon on the day of vaginal plug detection after overnight mating. For mutant mouse analysis, Nkx2.1 +/− heterozygous mutant breeding pairs were used to produce null mutants (Nkx2.1 −/− ), as well as heterozygous (Nkx2.1 +/− ) and wildtype (Nkx2.1 +/+ ) littermate controls. PCR on adult or embryo tail DNA was used to identify genotype, using primers for Neo and Nkx2.1 as described previously (Kimura et al., 1996) .
In situ NP cell labeling
The micron-sized particles of iron oxide (MPIO) contrast agent used was a (dragon) green fluorescent polystyrene-divinylbenzene coated particle with a mean diameter of 1.63 μm (Bangs Laboratories), and mean iron content of 1 pg per particle (Shapiro et al., 2005) . In utero injection of MPIO into the embryonic mouse brain was performed using UBM-guidance (Olsson et al., 1997; Wichterle et al., 2001) , targeting the MGE at E11.5 to E13.5 or the LGE at E12.5 to E13.5. Pregnant mice were anesthetized with intraperitoneal (IP) pentobarbital, the abdomen shaved and sterilized, and midline laparotomy performed. Each uterine horn was externalized to assess the number and distribution of embryos, and then carefully replaced within the abdomen. The mouse was placed supine in a custom holder allowing for positioning of a modified Petri dish over the abdomen, as described in detail previously (Liu et al., 1998) . The 65-mm plastic Petri dish was modified, removing a 30-mm diameter circular aperture from the center, and attaching a thin rubber membrane over the aperture. A 15 mm slit was cut in the rubber membrane to allow access to the uterus, through the laparotomy. The rubber membrane provided a seal between the plastic plate and the shaved abdomen, allowing the dish, which was filled with sterile phosphate buffered saline (PBS), to continuously bathe the uterus. The embryos (within the uterus) were carefully pulled through the slit in the membrane and positioned with gentle stabilization by the membrane itself. Embryos were visualized within the uterus using a commercial UBM system (Vevo 770, VisualSonics) with a 40 MHz transducer. Once the MGE or LGE was identified morphologically, a 50 μm diameter beveled glass needle loaded with particle solution was advanced, under real-time UBM guidance, through the uterus and into the selected brain region. Particle solution (10-25 nL; approximately 10,000 particles per nL) was delivered using a micro-injector system (Narishige), and the needle was withdrawn. After all selected embryos were injected, the laparotomy was closed with continuous silk sutures in the abdominal muscle and staples or interrupted silk sutures in the skin. The mouse was allowed to recover in a warm cage until fully awake.
Ex vivo micro-MRI
To prepare E18.5 embryos for ex vivo micro-MRI, the mother was euthanized with an overdose of IP pentobarbital and cervical dislocation, and the embryos were removed from the uterus and cardioperfused with 4% paraformaldehyde (PFA). Embryos were then post-fixed for approximately 3 h in 4% PFA at 4°C, washed in PBS, and mounted in a syringe phantom surrounded by Fomblin perfluoropolyether (Ausimont), which gives no proton NMR signal.
Ex vivo MRI data were acquired on a 7-Tesla micro-imaging system (SMIS), consisting of a horizontal bore magnet (Magnex Scientific) and an actively shielded 250 mT/m gradient insert (Magnex). Imaging was done using either a custom saddle coil (ID = 22 mm, length = 20 mm) or a commercial quadrature Litzcage coil (ID = 25 mm, length = 22 mm; Doty Scientific). T2*-weighted 3D gradient-echo imaging was performed in 10 h overnight sessions including both 100-μm (2 h) and 50-μm (8 h) isotropic resolution scans with the following sequence parameters: repetition time, TR = 50-ms; echo time, TE = 15-ms; flip angle, FA = 18°; field of view, FOV = (25.6 mm) 3 ;
image matrix (100-μm) = 256 
Image analysis
Image analysis and segmentation was done using Analyze (AnalyzeDirect) and Amira (Visage Imaging) software packages. Each brain was segmented from the 3D micro-MRI dataset using a semiautomated method of seeding with manual editing to remove nonneural tissues when necessary. The remnant of the injection site (IS) was identified as the largest dark region in the ventral brain. The center of the IS was identified using the "Magic Wand Selection" function to define the dark injection site, and decreasing the region in all dimensions 3 times using the "Shrink Selection" function of the Amira Segmentation Editor, where the "Magic Wand Selection" and "Shrink Selection" are proprietary functions of the Amira software. Dark regions representing MPIO-labeled migratory cells were segmented automatically in Amira using a threshold defined by Rose's criterion, where signal intensity 5 standard deviations (SD) or more below the mean background signal (Haacke et al., 1999) . For these analyses, the mean signal intensity and standard deviation were measured in the (unlabeled) brain region contralateral to the MPIO injection. On micro-MRI, particles were often observed to have leaked into and spread within the cerebral ventricles. To improve meaningful appreciation of MPIO-labeled cell migration in the segmented volumes, regions of signal loss within the ventricular system were manually subtracted from the segmented volume.
Histology and immunohistochemistry
Following micro-MRI, fixed samples were removed from the phantom, equilibrated sequentially with 15% and 30% sucrose solution at 4°C for cryoprotection, embedded in "Optimal Cutting Temperature", OCT compound (Tissue-Tek®, Sakura Finetek USA) and frozen for cryosectioning (12-20 μm sections). Sections used for correlation with MRI were washed and stained with 4′,6-diamidino-2-phenylindole (DAPI) nuclear counterstain. For correlation, fluorescence images from three sequential 20-μm thick coronal sections were acquired and overlayed on Photoshop (Adobe) for comparison with a matched coronal image from the 50-μm resolution MRI dataset.
Immunohistochemistry (IHC) for detection of Tuj1 (pan-neuronal marker), Iba1 (microglial marker) and PDGFRα (oligodendrocyte marker) used the following general protocol: slides were washed in phosphate-buffered saline (PBS) followed by blocking in PBS with 0.1% triton X-100 (PBS-T) and 10% normal goat serum (NGS). Primary antibody solution (PBS-T with 1% NGS and antibody [anti-tuj-1 (Covance) at 1:1000 dilution; anti-Iba1 (Wako) 1:1000; anti-PDGFRα (BD Pharminigen) 1:500]) was pipetted onto slides, which were kept in a wet box at 4°C overnight. Slides were washed in PBS followed by application of the secondary antibody solution: PBS-T with 1% NGS and antibody [Fluorescein isothiocyanate (FITC)-conjugated goat antimouse IgG (Jackson) 1:200; Cyanine3 (Cy3)-conjugated goat antirabbit IgG (Jackson) 1:200]. After 1 h at room temperature in a dark wet box, slides were washed (PBS x 3) and coverslipped with watersoluble mounting medium (Biomeda). Nuclear DAPI counterstain was used where noted in the first wash (1:10,000 in PBS). Fluorescence images were acquired on a Leica (Leitz DM RXE) microscope with a CCD camera (Pixelfly).
Quantitative histological analysis was done by identifying a total of 50-100 MPIO-labeled cells on single or double-labeled sections from three separate embryos and counting whether the MPIO-labeled cells were positive or negative for the marker used. Percentages were calculated from each embryo; error bars represent the standard deviation of values from the three embryos in each set: WT MGE, WT LGE, and Nkx2.1 LGE.
Results
In situ injections of MPIO effectively targeted MGE or LGE progenitor zones
UBM image-guidance enabled real-time visualization and placement of the glass micro-capillary needle tip in either the MGE or LGE for accurate injection of MPIO (Fig. 2a,b) . Although the needle produced a large reflection artifact on UBM, the tip of the needle was reliably identifiable during injection. Correct targeting of the MPIO was verified using micro-MRI of embryos, fixed and imaged immediately after injection, which showed prominent dark artifacts from the MPIO injected into the MGE or LGE (N = 3 each; Fig. 2c,d ). These results were further validated using fluorescence microscopy of matched histological sections, showing the localization of (green) MPIO particles in the injected regions (N = 3; Fig. 2e,f) . Comparison between histology and micro-MRI showed the expected blooming effect of the MPIO, with the region of signal loss much larger than the actual size of the particle deposit.
Quantification of micro-MRI signal changes due to MPIO particles
After injection of MPIO particles into the E12.5 MGE, embryos were analyzed at E18.5 with both micro-MRI and histology to determine the effect of MPIO on MRI signal intensity (Fig. 3) . Particles were often observed within the ventricular system at MRI and histology; however, labeled cells were only found within the brain parenchyma on the side ipsilateral to the injection. Control injections into the ventricle at time points between E10.5 and E14.5, failed to result in cell labeling within the brain parenchyma in our experiments. Comparison of micro-MRI and matched histological sections after MGE injections showed good qualitative agreement between locations of the largest particles on fluorescence microscopy ( Fig. 3a) with the largest dark spots on micro-MRI (Fig. 3b) . Rare cases where dark spots on micro-MRI did not correlate with particles on histology were likely due to particle loss during tissue sectioning and staining. To further analyze the relationship between MPIO and micro-MRI signal change, the Rose criterion (signal change ≥5 SD of background signal) was tested as a quantitative method for determining the threshold for segmenting MPIO particles on micro-MRI (Haacke et al., 1999) , measuring line profiles through dark spots confirmed to be particles on histology (N = 10) and an equal number of non-particle regions (N = 10) (Fig. 3c) . All confirmed particles were identified with thresholding based on the Rose criterion, while none of the non-particle regions were identified. Based on these results, the threshold for segmenting MPIOs on micro-MRI was set at 5 SD below the (contralateral) background signal for all subsequent analyses.
Micro-MRI demonstrated 3D cell migration patterns after MGE and LGE labeling
To assess the ability of micro-MRI to visualize patterns of NP cell migration, MPIO were injected into E11.5 to E13.5 MGE and E12.5 to E13.5 LGE using UBM image guidance. The embryos were then allowed to develop normally in utero for 5-7 days, and micro-MRI was performed at E18.5, one day before birth. Following MGE injection, micro-MRI showed wide dispersion of particles away from the injection site into the ipsilateral cortex (N = 16; Fig. 4a,b) . In contrast, after LGE injection micro-MRI showed local dispersion of particles throughout the striatum, as well as anterior movement in the (ipsilateral) rostral migratory stream (RMS) to the olfactory bulb (OB) (N = 12; Fig. 4c,d ). Although MPIO particles were frequently observed bilaterally in the cerebral ventricles, most likely due to leakage during the injection, it is notable that MPIO-labeling in the brain tissue was invariably only observed ipsilateral to the injection site, consistent with the known NP migration pathways that do not cross the midline. Segmentation of the labeled voxels in the MGE and LGE datasets clearly revealed the expected 3D patterns of NP cell migration from the MGE (Fig. 4e) and LGE (Fig. 4f ) in individual mouse embryos. Although higher resolution (50-μm isotropic) imaging was used for segmenting the MPIO particles in this study, it was interesting that lower resolution (100-μm isotropic) was effectively able to demonstrate the same overall patterns of particle distributions in a time scale (2-h acquisition time) compatible with in vivo imaging (Suppl. Fig. 1 ).
Immunohistochemistry shows that most migrating MPIO-labeled cells are neurons
IHC analysis of histological sections was performed after E18.5 micro-MRI to assess whether the particles were internalized in neural cells, and to determine the cell types labeled with MPIO (Fig. 5) . Quantitative analyses after IHC of MGE-injected brains demonstrated expression of Tuj1 in the vast majority (N 85%) of MPIO labeled cells in the cortex, while LGE-injected brains demonstrated Tuj1 expression in most (N80%) MPIO labeled cells in the striatum and external layers of the olfactory bulb. These results show that most MPIO labeled migrating cells were Tuj1-expressing neurons. After both MGE and LGE injections, labeled cells near the IS were either Tuj1-expressing neurons (Tuj1+) or Iba1-expressing microglia. Although it has been shown that a subset of cortical oligodendrocytes also arise from the MGE during embryogenesis (Kessaris et al., 2006) , MPIO was almost never found in PDGFRα-expressing oligodendrocytes in MGE-injected brains. In addition, MPIO-labeled cells in the RMS or central OB of LGE-injected brains were often not Tuj1-positive, possibly because they were insufficiently mature to express this neuronal marker. These results demonstrate that MPIO labeled the migrating neuronal populations known to arise from the MGE and LGE at the developmental stages investigated.
Micro-MRI reveals rostral-caudal differences in migration within the MGE and LGE
MPIO labeling and 3D micro-MRI was used to investigate differences in NP cell migration patterns from different sub-regions within the MGE and LGE, an area about which little has been reported. 3D MPIO distributions were segmented from micro-MRI images of MGE-and LGEinjected embryos, and each IS determined retrospectively from the densest regions of MPIO labeling within the MGE or LGE (Fig. 6) . Cell migration patterns from injections along the rostral-caudal extent of each progenitor zone were then registered to a common 3D space for comparison. Migration from within the MGE showed a similar wide distribution throughout the dorsal cortex from each IS (typical N = 3 distributions, Fig. 6a,b ; Suppl. Fig. 2a-c) . Although subtle, the data suggested that there might be a slight increase in rostral migration from more caudal regions of MGE, a result that requires further investigation to verify. In contrast, migration from within the LGE demonstrated a clear rostral-caudal organization, with more rostral sub-regions giving rise to NP cells that migrate in the RMS to the OB, while more caudal sub-regions demonstrated mostly local migration within the striatum (typical N = 3 distributions, Fig. 6c,d ; Suppl. Fig. 2 d-f ).
Micro-MRI demonstrates altered migration patterns in Nkx2.1 −/− mutant mice Nkx2.1 is expressed in the MGE, and not the LGE, during embryonic brain development, and Nkx2.1 −/− mutant embryos do not form a morphological MGE, being described as having a ventral to dorsal transformation of (mutant) MGE into an LGE fate (Sussel et al., 1999) . UBM images clearly demonstrated the Nkx2.1 −/− mutant phenotype of the Nkx2.1 −/− embryo, showing a single ganglionic eminence, presumably the LGE (Fig. 7a,b) . After in utero UBM-guided injection of MPIO into the E12.5 Nkx2.1 −/− LGE, micro-MRI at E18.5 sometimes showed normal LGE migration patterns (N = 5/16; Fig. 7c ), but often demonstrated abnormal migration, suggesting a combination of the normal MGE and
LGE patterns (N = 11/16; Fig. 7d ). In addition, embryos with more rostral MPIO injections resulted in more labeling in the RMS, OB and frontal cortex, while more caudal injections resulted in a more disperse (MGElike) pattern of cortical labeling (typical distributions, N = 4; Fig. 7e,f ; Suppl. Fig. 3 ). IHC analysis in E18.5 Nkx2.1 −/− embryos showed that MPIO-labeled cells in both cortex and striatum were predominantly Tuj1-expressing neurons, while labeled cells in the IS were both neurons and Iba1-expressing microglia (Fig. 8) . Similar to WT embryos, MPIO-labeled cells in the RMS and central OB, expected to be the most immature NP cells, were often not Tuj1-positive. Taken together, these data are consistent with the proposed ventral origin of a population of cortical interneurons in Nkx2.1 −/− mutants, approximately half the WT number, still present in the mutant cortex at late embryonic stages (Sussel et al., 1999) .
Discussion
In this study, we demonstrated effective ultrasound-guided spatially and temporally targeted delivery of MPIO cellular contrast agent to two neuronal progenitor zones (MGE, LGE) in the mid-gestation embryonic mouse brain. At late embryogenesis, labeled progenitor migration was assessed on fixed brain samples using 3D T2*-weighted micro-MRI and histology. In WT embryos, robust migration from the MGE to the dorsal cortex, and from the LGE to the striatum and olfactory bulb were observed. The vast majority of MPIO-labeled cells in the cortex and olfactory bulb were confirmed by IHC to be neuronal, as expected, with only rare labeling of phagocytic microglia. We used a semiautomated, threshold-based segmentation method to visualize the 3D distributions of MPIO labeled cells. Comparison of multiple WT data sets demonstrated sub-populations of migratory cells along the rostral-caudal axis within both the MGE and LGE, which have not previously been described. Interestingly, migration from the LGE in Nkx2.1 −/− mutant embryos showed an expanded pattern of migration including a marked migration to the dorsal cortex, not observed in WT
LGE. This is the first MRI study of NP cell migration patterns in the embryonic mouse brain, specifically from the ventral MGE and LGE progenitor zones. Several molecular markers of ventral progenitor zones have been described, including Nkx2.1 (Sussel et al., 1999; Marin et al., 2000; Xu et al., 2004; Cobos et al., 2006) however, it is likely that other factors have yet to be identified. Our approach may be helpful for future studies in identifying and characterizing the molecular origins of these subpopulations. Ongoing studies have expanded MRI to the in utero setting, which could allow future investigations exploring the temporal nature of these migratory processes longitudinally in living embryos (Deans et al., 2008; Berrios-Otero et al., 2012) . Preliminary data at 100-μm isotropic resolution (Suppl. Fig. 1) , which has recently been demonstrated to be feasible for in utero MRI (Parasoglou et al., 2013) , together with previous reports of cell tracking in postnatal mice at the same resolution Granot et al., 2011) , are encouraging that the overall migration pattern would still be appreciable at the lower resolution required for in vivo imaging. However, technical challenges remain for in vivo cell migration mapping in mouse embryos, including correction of artifacts due to physiologic motion of the mother and fetus during imaging, differentiating MPIO signal from the endogenous T2* effect of the fetal vasculature, potential toxicity related to multiple gestational exposures to anesthesia, and the challenge of reproducibly identifying a specific embryo within each litter.
Mapping the migrating NP cells in this study depended on the sensitivity of detecting MPIO particles with T2*-weighted gradient-echo MRI. This sensitivity is not without cost, since the T2* blooming effect also caused the distortion of the images around the injection site (e.g., Fig. 2 ). In our application, MPIO uptake and ex vivo T2*-weighted micro-MRI provided an excellent method for visualizing the relatively sparse patterns of migrating NP cells within the surrounding anatomy of the cortex, striatum and olfactory bulbs, which were sufficiently removed from the injection site, where anatomical details were obscured by the blooming effect. In future, a multi-echo gradient echo sequence (using a shorter echo to visualize the injection site and a longer echo to detect the isolated MPIO particles), or a combination of T2-weighted spin-echo (injection site) and T2*-weighted gradient-echo LGE injection (d-f), the majority of MPIO-labeled cells away from the IS, in both the striatum (St; d) and olfactory bulb (OB; e) were neuronal (h), with microglia also being labeled near the IS (f, h). Within the subventricular zone (SVZ) and rostral migratory stream (RMS), including the central part of the OB, many labeled cells were neither Iba1-positive nor Tuj1-positive (h). These cells likely represent immature migrating neurons. Scale bars in panels (a) and (e) are 30 μm. Data in panels (g, h) were plotted as mean ± SD. In panels (a-f), MPIO particles are green, cell-specific markers (Tuj1, Iba1, PDGFRα) are red, and non-specific nuclear stain (DAPI) is blue. (MPIO particles), might enable more accurate assessment of anatomical detail and particle distribution near the injection site.
Our results illustrate the potential for phenotypic studies of mutant embryos with altered neuronal migration patterns such as the Nkx2.1 −/− model. In the Nkx2.1 knockout mouse (Kimura et al., 1996) , the MGE, thought to represent the primary source of cortical interneurons, has been described to be molecularly re-specified to LGE cell fate (Sussel et al., 1999) . However, loss of the MGE in Nkx2.1 −/− mice results in loss of only half of the cortical interneuron population. Further studies have demonstrated that these remaining molecularly distinct cortical interneurons likely originate in the caudal ganglionic eminence (CGE) Butt et al., 2005; Miyoshi et al., 2010) . The migration patterns demonstrated by micro-MRI suggest that these CGE progenitors and the molecular-LGE progenitors may be spatially co-localized within the monolithic Nkx2.1 −/− ganglionic eminence, particularly caudally. This may imply that Nkx2.1 normally acts to generate a boundary to NP cells originating in the CGE, so that in the absence of Nkx2.1 the CGE progenitors can move more rostrally during embryonic brain development.
In conclusion, this study represents a significant methodological advance for mouse neurodevelopment research. Taken together, our results have broad implications for future investigation of NP cell migration in the embryonic mouse brain.
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